261 related articles for article (PubMed ID: 21777851)
1. Recent progress in the genetics of generalized vitiligo.
Spritz RA
J Genet Genomics; 2011 Jul; 38(7):271-8. PubMed ID: 21777851
[TBL] [Abstract][Full Text] [Related]
2. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.
Spritz RA
J Invest Dermatol; 2012 Feb; 132(2):268-73. PubMed ID: 21993561
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Vitiligo.
Spritz RA; Andersen GH
Dermatol Clin; 2017 Apr; 35(2):245-255. PubMed ID: 28317533
[TBL] [Abstract][Full Text] [Related]
4. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
[TBL] [Abstract][Full Text] [Related]
5. The genetics of generalized vitiligo.
Spritz RA
Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
[TBL] [Abstract][Full Text] [Related]
6. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.
Alkhateeb A; Qarqaz F
Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744
[TBL] [Abstract][Full Text] [Related]
7. The genetics of generalized vitiligo and associated autoimmune diseases.
Spritz RA
Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960
[TBL] [Abstract][Full Text] [Related]
8. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population.
Laberge GS; Birlea SA; Fain PR; Spritz RA
Pigment Cell Melanoma Res; 2008 Apr; 21(2):206-8. PubMed ID: 18426414
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo--part 1.
Tarlé RG; Nascimento LM; Mira MT; Castro CC
An Bras Dermatol; 2014; 89(3):461-70. PubMed ID: 24937821
[TBL] [Abstract][Full Text] [Related]
10. Physiopathology and genetics of vitiligo.
Passeron T; Ortonne JP
J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
[TBL] [Abstract][Full Text] [Related]
11. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
LaBerge GS; Bennett DC; Fain PR; Spritz RA
J Invest Dermatol; 2008 Jul; 128(7):1757-62. PubMed ID: 18200060
[TBL] [Abstract][Full Text] [Related]
12. The genetics of generalized vitiligo and associated autoimmune diseases.
Spritz RA
J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
[TBL] [Abstract][Full Text] [Related]
13. The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.
Wang P; Li Y; Nie H; Zhang X; Shao Q; Hou X; Xu W; Hong W; Xu A
J Dermatol Sci; 2016 Oct; 84(1):40-49. PubMed ID: 27470284
[TBL] [Abstract][Full Text] [Related]
14. Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).
Jin Y; Riccardi SL; Gowan K; Fain PR; Spritz RA
J Invest Dermatol; 2010 Mar; 130(3):774-83. PubMed ID: 19727120
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.
Birlea SA; Jin Y; Bennett DC; Herbstman DM; Wallace MR; McCormack WT; Kemp EH; Gawkrodger DJ; Weetman AP; Picardo M; Leone G; Taïeb A; Jouary T; Ezzedine K; van Geel N; Lambert J; Overbeck A; Fain PR; Spritz RA
J Invest Dermatol; 2011 Feb; 131(2):371-81. PubMed ID: 21085187
[TBL] [Abstract][Full Text] [Related]
16. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.
Spritz RA
Thyroid; 2010 Jul; 20(7):745-54. PubMed ID: 20578892
[TBL] [Abstract][Full Text] [Related]
17. NALP1 in vitiligo-associated multiple autoimmune disease.
Jin Y; Mailloux CM; Gowan K; Riccardi SL; LaBerge G; Bennett DC; Fain PR; Spritz RA
N Engl J Med; 2007 Mar; 356(12):1216-25. PubMed ID: 17377159
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population.
Jin Y; Birlea SA; Fain PR; Spritz RA
J Invest Dermatol; 2007 Nov; 127(11):2558-62. PubMed ID: 17637824
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
Jin Y; Andersen G; Yorgov D; Ferrara TM; Ben S; Brownson KM; Holland PJ; Birlea SA; Siebert J; Hartmann A; Lienert A; van Geel N; Lambert J; Luiten RM; Wolkerstorfer A; Wietze van der Veen JP; Bennett DC; Taïeb A; Ezzedine K; Kemp EH; Gawkrodger DJ; Weetman AP; Kõks S; Prans E; Kingo K; Karelson M; Wallace MR; McCormack WT; Overbeck A; Moretti S; Colucci R; Picardo M; Silverberg NB; Olsson M; Valle Y; Korobko I; Böhm M; Lim HW; Hamzavi I; Zhou L; Mi QS; Fain PR; Santorico SA; Spritz RA
Nat Genet; 2016 Nov; 48(11):1418-1424. PubMed ID: 27723757
[TBL] [Abstract][Full Text] [Related]
20. The Genetic Basis of Vitiligo.
Spritz RA; Santorico SA
J Invest Dermatol; 2021 Feb; 141(2):265-273. PubMed ID: 32778407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
